Pubblicazioni

Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII). a multicentre, open-label, phase 3b, randomised controlled trial

2019 - THE LANCET DIABETES & ENDOCRINOLOGY

Aroda, Vr; GonzÃ¡lez-Galvez, G; GrÃ¸n, R; Halladin, N; HaluzÃk, M; Jermendy, G; Kok, A; Årsy, P; Sabbah, M; Sesti, G; Silver, R.

An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases

2019 - RHEUMATOLOGY ADVANCES IN PRACTICE

Reggia, Rossella; Andreoli, Laura; Sebbar, Houssni; Canti, Valentina; Ceccarelli, Fulvia; Favaro, Maria; Hoxha, Ariela; Inversetti, Annalisa; Larosa, Maddalena; Ramoni, Veronique; Caporali, Roberto; Conti, Fabrizio; Doria, Andrea; Montecucco, Carlomaurizio; Rovere-Querini, Patrizia; Ruffatti, Amelia; Valesini, Guido; Zatti, Sonia; Fallo, Luca; Lojacono, Andrea; Tincani, Angela

Off-label use of ceftaroline fosamil: a systematic review

2019 - INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pani, Arianna; Colombo, Fabrizio; Agnelli, Francesca; Frantellizzi, Viviana; Baratta, Francesco; Pastori, Daniele; Scaglione, Francesco